{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T21:06:05Z","timestamp":1772053565260,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001793","name":"Queensland University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clnesp.2025.04.006","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:23:24Z","timestamp":1745501004000},"page":"714-720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Assessment of dietary intake in adults with cystic fibrosis pre and post commencement of Elexacaftor\/Tezacaftor\/Ivacaftor"],"prefix":"10.1016","volume":"67","author":[{"given":"Felicity","family":"Loel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Keith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenonah","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Herd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Matson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clnesp.2025.04.006_bib1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201009-1478CI","article-title":"Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life","volume":"183","author":"Cohen-Cymberknoh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clnesp.2025.04.006_bib2","article-title":"Full guideline: nutrition guidelines for cystic fibrosis in Australia and New Zealand","author":"Saxby","year":"2017","journal-title":"Thorac Soc Australia and New Zealand"},{"issue":"7","key":"10.1016\/j.clnesp.2025.04.006_bib3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jand.2020.03.014","article-title":"Effect of CFTR modulators on anthropometric parameters in individuals with cystic fibrosis: an evidence analysis center systematic review","volume":"121","author":"Bailey","year":"2021","journal-title":"J Acad Nutr Diet"},{"issue":"6","key":"10.1016\/j.clnesp.2025.04.006_bib4","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jcf.2023.06.010","article-title":"Body mass index and nutritional intake following elexacaftor\/Tezacaftor\/Ivacaftor modulator therapy in adults with cystic fibrosis","volume":"22","author":"Caley","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.clnesp.2025.04.006_bib5","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.clnu.2019.12.029","article-title":"Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors","volume":"39","author":"Bonhoure","year":"2020","journal-title":"Clin Nutr (Phila)"},{"issue":"1","key":"10.1016\/j.clnesp.2025.04.006_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcf.2021.05.002","article-title":"Overweight and obesity in adults with cystic fibrosis: an Italian multicenter cohort study","volume":"21","author":"Gramegna","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.clnesp.2025.04.006_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2019.10.004","article-title":"Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: a single-center analysis","volume":"19","author":"Harindhanavudhi","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.clnesp.2025.04.006_bib8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jcf.2023.10.002","article-title":"Alterations in lipids after initiation of highly effective modulators in people with cystic fibrosis","volume":"22","author":"Despotes","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.clnesp.2025.04.006_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/phar.2903","article-title":"Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis","volume":"44","author":"Lonabaugh","year":"2023","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.clnesp.2025.04.006_bib10","first-page":"1340388","article-title":"What the future holds: cystic fibrosis and aging","volume":"10","author":"Blankenship","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.clnesp.2025.04.006_bib11","first-page":"874","article-title":"What do people with cystic fibrosis eat? Diet quality, macronutrient and micronutrient intakes (compared to recommended guidelines) in adults with cystic fibrosis: a systematic review","volume":"23","author":"Greaney","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.clnesp.2025.04.006_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/1747-0080.12882","article-title":"Dietary intake and quality among adults with cystic fibrosis: a systematic review","author":"Thornton","year":"2024","journal-title":"Nutr Diet"},{"key":"10.1016\/j.clnesp.2025.04.006_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/88.2.324","article-title":"The US department of agriculture automated multiple-pass method reduces bias in the collection of energy intakes","volume":"88","author":"Moshfegh","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.04.006_bib14","series-title":"Foodworks","year":"2019"},{"key":"10.1016\/j.clnesp.2025.04.006_bib16","series-title":"Eat for health \u2013 educator guide","year":"2013"},{"key":"10.1016\/j.clnesp.2025.04.006_bib17","series-title":"Apparent consumption of selected foodstuffs","year":"2024"},{"key":"10.1016\/j.clnesp.2025.04.006_bib18","series-title":"Dietary behaviour [Internet]. Canberra: ABS","year":"2022"},{"key":"10.1016\/j.clnesp.2025.04.006_bib19","series-title":"The statistical package for social sciences","year":"2022"},{"issue":"4","key":"10.1016\/j.clnesp.2025.04.006_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000538606","article-title":"Improved nutritional outcomes and gastrointestinal symptoms in adult cystic fibrosis patients treated with elexacaftor\/Tezacaftor\/Ivacaftor","volume":"42","author":"Stastna","year":"2024","journal-title":"Dig Dis"},{"issue":"2","key":"10.1016\/j.clnesp.2025.04.006_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/jhn.12527","article-title":"Dietary intake in people consuming a low-carbohydrate diet in the UK biobank","volume":"31","author":"Shafique","year":"2018","journal-title":"J Hum Nutr Diet"},{"issue":"12","key":"10.1016\/j.clnesp.2025.04.006_bib23","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.jada.2007.09.005","article-title":"Nutrient status of adults with cystic fibrosis","volume":"107","author":"Gordon","year":"2007","journal-title":"J Am Diet Assoc"},{"issue":"9","key":"10.1016\/j.clnesp.2025.04.006_bib24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jand.2020.05.011","article-title":"Sodium status and replacement in children and adults living with cystic fibrosis: a narrative review","volume":"120","author":"Declercq","year":"2020","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.clnesp.2025.04.006_bib25","doi-asserted-by":"crossref","first-page":"877118","DOI":"10.3389\/fphar.2022.877118","article-title":"Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-Specific CFAbd-Score","volume":"13","author":"Mainz","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.04.006_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40348-024-00178-6","article-title":"Changes in vitamins and trace elements after initiation of highly effective CFTR modulator therapy in children and adults with cystic fibrosis - a real-life insight","volume":"11","author":"Fabricius","year":"2024","journal-title":"Mol Cell Pediatr"},{"issue":"6","key":"10.1016\/j.clnesp.2025.04.006_bib27","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcf.2023.08.002","article-title":"The impact of elexacaftor\/tezacaftor\/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosis","volume":"22","author":"Hergenroeder","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.clnesp.2025.04.006_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcf.2004.04.003","article-title":"Vitamin A levels in patients in patients with CF are influenced by the inflammatory response","volume":"3","author":"Greer","year":"2004","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.clnesp.2025.04.006_bib29","article-title":"The changing landscape of treatment for cystic fibrosis related diabetes","volume":"35","author":"Amini","year":"2024","journal-title":"J Clin Transl Endocrinol"},{"issue":"7","key":"10.1016\/j.clnesp.2025.04.006_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28508","article-title":"Real-world effectiveness of elexacaftor\/tezacaftor\/ivacaftor on the burden of illness in adolescents and adults with cystic fibrosis","volume":"10","author":"Keens","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.clnesp.2025.04.006_bib31","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3389\/fendo.2019.00850","article-title":"Validity of dietary assessment methods when compared to the method of doubly labeled water: a systematic review in adults","volume":"10","author":"Burrows","year":"2019","journal-title":"Front Endocrinol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725002748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725002748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:27:13Z","timestamp":1762622833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725002748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":29,"alternative-id":["S2405457725002748"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.04.006","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of dietary intake in adults with cystic fibrosis pre and post commencement of Elexacaftor\/Tezacaftor\/Ivacaftor","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}